Letter to the editor regarding: Influence of CYP2D6 polymorphisms on tamoxifen side effects in patients with breast cancer
Crossref DOI link: https://doi.org/10.1007/s12094-025-03953-7
Published Online: 2025-05-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Qi https://orcid.org/0000-0002-0201-1075
Text and Data Mining valid from 2025-05-12
Version of Record valid from 2025-05-12
Article History
Received: 28 April 2025
Accepted: 6 May 2025
First Online: 12 May 2025
Declarations
:
: The authors declare that there are no competing interests.
: Not applicable.
: For this type of study, no informed consent is required.